Quick Asked: Surface Oncology Contact Us?

Are you searching for Surface Oncology Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 27 Apr, 2024 84 Views

What is sursurface oncologys mailing address? Surface Oncology's mailing address is 50 HAMPSHIRE STREET 8TH FLOOR, CAMBRIDGE MA, 02139. The company can be reached via phone at (617) 714-4096 or via email at [email protected].

Why surface oncology? Our perse clinical and preclinical pipeline of immune-enhancing antibody candidates target the innate and adaptive arms of the immune system to deliver dramatically different therapies for patients and their families. Surface Oncology is driven to deliver transformational outcomes for people with cancer who have no effective treatment options.

Is surface oncology a registered trademark? SURFACE ONCOLOGY and the Surface Oncology logo are registered trademarks of Surface Oncology, Inc. All rights reserved. 50 Hampshire Street, 8th Floor Cambridge, MA 02139

What is sursurface oncology doing about srf231? Surface Oncology is conducting a study of SRF231 in patients with advanced solid and hematologic cancers. For more information see www.clinicaltrials.gov. The Surface team is committed to scientific exchange and continual learning, from each other, from our work and from experts around the world, to break through scientific challenges.

Listing Results Surface Oncology Contact Us? Question Answers

Break Through Surface Oncology

Surface Oncology is developing next generation immunotherapies that target the immune-suppressive tumor microenvironment to attack cancer. Join Us + Surface Oncology Life Under the Surface; Contact

About Us Surface Oncology

Surface received an upfront payment of $85 million from GSK and is entitled to an additional $730 million in future milestone payments, as well as tiered royalties on global net sales. Are you interested in partnering with Surface? Please contact us at [email protected].

Press Releases Surface Oncology

Surface Oncology to Collaborate with Roche on Immuno-Oncology Study Evaluating SRF388, Targeting IL-27, as Part of a Novel Combination in Patients with Advanced Treatment-naïve Hepatocellular Carcinoma. Read More. May 5, 2021.

Surface Oncology Announces First Patient Dosed in Clinical

Surface Oncology Announces First Patient Dosed in Clinical Trial of Immuno-Oncology Antibody SRF388. CAMBRIDGE, Mass., April 23, 2020 (GLOBE NEWSWIRE) -- Surface Oncology (Nasdaq: SURF), a

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.
  1. Home ›
  2. S ›
  3. Surface Oncology Contact Us?